Eculizumab in chemotherapy-induced thrombotic microangiopathy

Thrombotic microangiopathy (TMA) is a rare but severe complication of tumors and their chemotherapeutic treatment. We report on two patients with chemotherapy-induced TMA who were successfully treated with a short course of the terminal complement inhibitor eculizumab. Both patients quickly achieved...

Full description

Saved in:
Bibliographic Details
Published in:Clin Nephrol Case Stud
Main Authors: Schulte-Kemna, Lena, Reister, Barbara, Bettac, Lucas, Ludwig, Ulla, Fürst, Daniel, Mytilineos, Joannis, Bergmann, Carsten, van Erp, Rene, Schröppel, Bernd
Format: Artigo
Language:Inglês
Published: Dustri-Verlag Dr. Karl Feistle 2020
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7171698/
https://ncbi.nlm.nih.gov/pubmed/32318323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CNCS109836
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items